Marker Therapeutics Liability on Credit Line (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.48 -0.10 (-6.33%) USD | NASDAQ | Feb 27, 16:00

1.48 0.00 (0.00%) After-Hours: 20:00

View Liability on Credit Line (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Liability on Credit Line (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Liability on Credit Line (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Liability on Credit Line (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--